Identifying differential networks based on multi-platform gene expression data.

Exploring how the structure of a gene regulatory network differs between two different disease states is fundamental for understanding the biological mechanisms behind disease development and progression. Recently, with rapid advances in microarray technologies, gene expression profiles of the same patients can be collected from multiple microarray platforms. However, previous differential network analysis methods were usually developed based on a single type of platform, which could not utilize the common information shared across different platforms. In this study, we introduce a multi-view differential network analysis model to infer the differential network between two different patient groups based on gene expression profiles collected from multiple platforms. Unlike previous differential network analysis models that need to analyze each platform separately, our model can draw support from multiple data platforms to jointly estimate the differential networks and produce more accurate and reliable results. Our simulation studies demonstrate that our method consistently outperforms other available differential network analysis methods. We also applied our method to identify network rewiring associated with platinum resistance using TCGA ovarian cancer samples. The experimental results demonstrate that the hub genes in our identified differential networks on the PI3K/AKT/mTOR pathway play an important role in drug resistance.

[1]  Yingying Lu,et al.  Inhibition of telomerase activity by HDV ribozyme in cancers , 2011, Journal of experimental & clinical cancer research : CR.

[2]  W. Hahn,et al.  Resistance to CDK2 Inhibitors Is Associated with Selection of Polyploid Cells in CCNE1-Amplified Ovarian Cancer , 2013, Clinical Cancer Research.

[3]  H. Zou,et al.  Sparse precision matrix estimation via lasso penalized D-trace loss , 2014 .

[4]  M. West,et al.  Sparse graphical models for exploring gene expression data , 2004 .

[5]  Caroline Dive,et al.  Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer , 2010, Cancer biology & therapy.

[6]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[7]  Muriel Médard,et al.  Network deconvolution as a general method to distinguish direct dependencies in networks , 2013, Nature Biotechnology.

[8]  Xing-Ming Zhao,et al.  Inferring gene regulatory networks from gene expression data by path consistency algorithm based on conditional mutual information , 2012, Bioinform..

[9]  Luonan Chen,et al.  Part mutual information for quantifying direct associations in networks , 2016, Proceedings of the National Academy of Sciences.

[10]  Bin Yu,et al.  Estimation Stability With Cross-Validation (ESCV) , 2013, 1303.3128.

[11]  Quaid Morris,et al.  PLIDA: cross-platform gene expression normalization using perturbed topic models , 2014, Bioinform..

[12]  N. Eckstein,et al.  Platinum resistance in breast and ovarian cancer cell lines , 2011, Journal of experimental & clinical cancer research : CR.

[13]  Xiaohua Hu,et al.  Identifying binary protein-protein interactions from affinity purification mass spectrometry data , 2015, BMC Genomics.

[14]  K. Aihara,et al.  Personalized characterization of diseases using sample-specific networks , 2016, bioRxiv.

[15]  J C Reed,et al.  The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2. , 1995, Oncogene.

[16]  M. Yuan,et al.  Model selection and estimation in the Gaussian graphical model , 2007 .

[17]  T. Okada,et al.  Upregulated expression of FGF13/FHF2 mediates resistance to platinum drugs in cervical cancer cells , 2013, Scientific Reports.

[18]  Diogo M. Camacho,et al.  Wisdom of crowds for robust gene network inference , 2012, Nature Methods.

[19]  E. Levina,et al.  Joint estimation of multiple graphical models. , 2011, Biometrika.

[20]  Patrick Danaher,et al.  The joint graphical lasso for inverse covariance estimation across multiple classes , 2011, Journal of the Royal Statistical Society. Series B, Statistical methodology.

[21]  D. Berney,et al.  The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancers. , 2010, The American journal of pathology.

[22]  Lin Yuan,et al.  Gene differential coexpression analysis based on biweight correlation and maximum clique , 2014, BMC Bioinformatics.

[23]  E. Schadt.  Molecular networks as sensors and drivers of common human diseases , 2009, Nature.

[24]  P. Zawierucha,et al.  Microarray-based detection and expression analysis of extracellular matrix proteins in drug‑resistant ovarian cancer cell lines. , 2014, Oncology reports.

[25]  Peng Yang,et al.  Detecting temporal protein complexes from dynamic protein-protein interaction networks , 2014, BMC Bioinformatics.

[26]  D. Soprano,et al.  Insulin receptor substrate-1 is an important mediator of ovarian cancer cell growth suppression by all-trans retinoic acid. , 2007, Cancer research.

[27]  Lincoln D. Stein,et al.  Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes , 2012, Nature.

[28]  W. Goessler,et al.  Plasmapheresis reverses all side-effects of a cisplatin overdose – a case report and treatment recommendation , 2006, BMC Cancer.

[29]  A. Fuente,et al.  From ‘differential expression’ to ‘differential networking’ – identification of dysfunctional regulatory networks in diseases , 2010 .

[30]  Joshy George,et al.  Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas , 2009, Clinical Cancer Research.

[31]  B. Kholodenko,et al.  The dynamic control of signal transduction networks in cancer cells , 2015, Nature Reviews Cancer.

[32]  K. Strimmer,et al.  Statistical Applications in Genetics and Molecular Biology A Shrinkage Approach to Large-Scale Covariance Matrix Estimation and Implications for Functional Genomics , 2011 .

[33]  Adrian V. Lee,et al.  Oncogenic Transformation by the Signaling Adaptor Proteins Insulin Receptor Substrate (IRS)-1 and IRS-2 , 2007, Cell cycle.

[34]  Stephen P. Boyd,et al.  Distributed Optimization and Statistical Learning via the Alternating Direction Method of Multipliers , 2011, Found. Trends Mach. Learn..

[35]  M. Konopleva,et al.  Raf-1 and Bcl-2 induce distinct and common pathways that contribute to breast cancer drug resistance. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  Xiao-Fei Zhang,et al.  Determining minimum set of driver nodes in protein-protein interaction networks , 2015, BMC Bioinformatics.

[37]  Matthias Ernst,et al.  Cancer research: past, present and future , 2011, Nature Reviews Cancer.

[38]  Xingming Zhao,et al.  Conditional mutual inclusive information enables accurate quantification of associations in gene regulatory networks , 2014, Nucleic acids research.

[39]  Hui Yu,et al.  Link-based quantitative methods to identify differentially coexpressed genes and gene Pairs , 2011, BMC Bioinformatics.

[40]  V. Beral,et al.  Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer , 2015, Nature Reviews Cancer.

[41]  T. Cai,et al.  Direct estimation of differential networks. , 2014, Biometrika.

[42]  T. Hubbard,et al.  A census of human cancer genes , 2004, Nature Reviews Cancer.

[43]  Kim-Anh Do,et al.  DINGO: differential network analysis in genomics , 2015, Bioinform..

[44]  Riet De Smet,et al.  Advantages and limitations of current network inference methods , 2010, Nature Reviews Microbiology.

[45]  Benjamin J. Raphael,et al.  Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.

[46]  H. Burris,et al.  Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway , 2013, Cancer Chemotherapy and Pharmacology.

[47]  Frank Emmert-Streib,et al.  Gene Sets Net Correlations Analysis (GSNCA): a multivariate differential coexpression test for gene sets , 2013, Bioinform..

[48]  Trupti Joshi,et al.  Inferring gene regulatory networks from multiple microarray datasets , 2006, Bioinform..

[49]  Su-In Lee,et al.  Node-based learning of multiple Gaussian graphical models , 2013, J. Mach. Learn. Res..

[50]  Lawrence Steinman,et al.  A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage , 2007, Nature Medicine.

[51]  Ralf Zimmer,et al.  Inferring gene regulatory networks by ANOVA , 2012, Bioinform..

[52]  Chris Wiggins,et al.  ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context , 2004, BMC Bioinformatics.

[53]  W. Wilson,et al.  Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas. , 1997, Blood.